... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapy in non smallcelllung cancer: a meta-analysis ... JL:Gemcitabine plus docetaxel as first-line chemotherapy inpatients with advanced non -small celllung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma-col 2007, 60:725-732.20. ... cisplatin-teniposide in patients withadvanced non -small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141.7....
... AccessPathological complete response induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, ... for patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, preoperative chemotherapy orradiotherapy might ... responses. Failure to obtain a response after the first few cycles should notautomatically discourage to continue treatment.IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode...
... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... ofdetecting EGFR mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor ... ofEGFR mutations in non -small- celllung cancer. Clin Cancer Res 2009,15:3023-3028.13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung adenocarcinoma: modification...
... are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer are associated with smoking, although ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,97:1558-1563.11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. LungCancer 2009, 65:13-18.12. ... HPVs in Asian lung cancer is 35.7%. The authors concluded that HPV maybe the second leading cause of lungcancerafter cigar-ette smoking.Although studies of viral-related lungcancer havebeen...
... treated with adjuvant chemotherapy after complete resection of non -small celllung carcinoma. Cancer Res 2010,70:8288-98.19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: what now? J ThoracOncol ... marker expression in tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... required for cancer cell growth. PLoS One 2008, 3:e2557.16. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecularprofiles in lungcancer diagnosis and prognosis. CancerCell 2006,9:189-98.17....
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... Research and Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non -Small CellLung Can-cer; SF-36:...
... gefitinib in non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients ... cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for ... ifosfamide in patients with advanced non -small- celllungcancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non -Small CellLungCancer Study Group. J Clin Oncol....
... non -small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non -small celllung ... non -small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small celllung ... for lungcancer varied greatly frominstitution to institution [10]. The most frequently usedschedule was 48 Gy in 4 fractions for both stage IA andIB primary lungcancer and metastatic lung cancer. As...
... Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC typically have a poor prognosis, ... Milano1*AbstractBackground: Standard therapy for metastatic non smallcelllungcancer (NSCLC) includes palliative systemic chemotherapy and/or radiotherapy. Recent studies of patients with ... Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non -small celllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul...
... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... radiotherapy for stage Inon -small celllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana university ... options for stage Inon -small celllung cancer. Oncologist 2008, 13:309-319.41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:Review of Hypofractionated Small Volume Radiotherapy...
... energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non -small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse P, ... reviewed the records of 115 patients with non -small cell lung cancer treated at our institution with definitive radiation therapy with or without concurrent chemotherapy (CHT). All patients were treated ... in non -small celllung cancer Erik P Sulman, Ritsuko Komaki, Ann H Klopp, James D Cox and Joe Y Chang*Address: Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer...
... phase III trial comparing two types of consolidation chemotherapy after concurrent chemoradiotherapy for limited-disease smallcelllung cancer. RTrequirements included a total dose of 45 Gy/30 ... phase III trial comparingtwo types of consolidation chemotherapyafter concurrentchemoradiotherapy for limited-disease smallcell lung cancer (Figure 1).The primary endpoint of JCOG 0202 was ... for Cancer Control and Information Services, National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and 3JCOG lungcancer study group, Thoracic Oncology Division, National Cancer...
... non -small celllungcancer (NSCLC).Methods: Based on 13 patients with locally advanced NSCLC, CT images acquired at treatmentplanning, midway and the end of the radio- (n = 1) or radiochemotherapy ... WagnerTH, Langen KM: Serial megavoltage CT imaging during exter-nal beam radiotherapy for non -small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol Biol Phys ... AccessResearchEvalution of surface-based deformable image registration for adaptive radiotherapy of non -small celllungcancer (NSCLC)Matthias Guckenberger*, Kurt Baier, Anne Richter, Juergen Wilbert and Michael...